These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9362347)

  • 21. Active form of human hepatocyte growth factor is excreted into bile after hepatobiliary resection.
    Kurumiya Y; Nimura Y; Takeuchi E; Nozawa K; Nagino M; Hayata A; Maeda A; Yoshida S
    J Hepatol; 1999 Jan; 30(1):22-8. PubMed ID: 9927147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peritoneal fluid contains high concentration of hepatocyte growth factor and vascular endothelial growth factor after resection for hepatocellular carcinoma.
    Hu RH; Ho MC; Wu YM; Lee PH
    Hepatogastroenterology; 2007; 54(75):862-5. PubMed ID: 17591080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum concentrations of human hepatocyte growth factor is a useful indicator for predicting the occurrence of hepatocellular carcinomas in C-viral chronic liver diseases.
    Yamagamim H; Moriyama M; Matsumura H; Aoki H; Shimizu T; Saito T; Kaneko M; Shioda A; Tanaka N; Arakawa Y
    Cancer; 2002 Aug; 95(4):824-34. PubMed ID: 12209727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The changes in circulating hepatocyte growth factor after partial hepatectomy in the baboon.
    Winters Z; Arendse H; Tyler M; Hickman R; Rowland G; Lombard C
    S Afr J Surg; 1999 May; 37(2):31-7. PubMed ID: 10450655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Portal branch ligation with a continuous hepatocyte growth factor supply makes extensive hepatectomy possible in cirrhotic rats.
    Kaido T; Yoshikawa A; Seto S; Yamaoka S; Sato M; Ishii T; Imamura M
    Hepatology; 1998 Sep; 28(3):756-60. PubMed ID: 9731569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Determination and clinical significance of human hepatocyte growth factor in serum].
    Takemura M; Furuta N; Nakamura S; Okuno M; Seishima M; Noma A; Sugihara J; Murakami N; Sugiyama H; Moriwaki H
    Rinsho Byori; 1992 Nov; 40(11):1168-72. PubMed ID: 1307623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevation of serum hepatocyte growth factor concentration in patients with gastric cancer is mediated by production from tumor tissue.
    Beppu K; Uchiyama A; Morisaki T; Nakamura K; Noshiro H; Matsumoto K; Nakamura T; Tanaka M; Katano M
    Anticancer Res; 2000; 20(2B):1263-7. PubMed ID: 10810432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatocyte growth factor levels in liver and serum increase during chemical hepatocarcinogenesis.
    Burr AW; Hillan KJ; McLaughlin KE; Ferrier R; Chapman C; Mathew J; Burt AD
    Hepatology; 1996 Nov; 24(5):1282-7. PubMed ID: 8903411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alteration in levels of human hepatocyte growth factor following hepatectomy.
    Nishizaki T; Takenaka K; Yoshizumi T; Yanaga K; Soejima Y; Shirabe K; Sugimachi K
    J Am Coll Surg; 1995 Jul; 181(1):6-10. PubMed ID: 7599773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocyte growth factor accelerates the proliferation of hepatic oval cells and possibly promotes the differentiation in a 2-acetylaminofluorene/partial hepatectomy model in rats.
    Hasuike S; Ido A; Uto H; Moriuchi A; Tahara Y; Numata M; Nagata K; Hori T; Hayashi K; Tsubouchi H
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1753-61. PubMed ID: 16246197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Portal and systemic serum growth factor and acute-phase response after laparotomy or partial hepatectomy in patients with colorectal liver metastases: a prognostic role for C-reactive protein and hepatocyte growth factor.
    de Jong KP; Hoedemakers RM; Fidler V; Bijzet J; Limburg PC; Peeters PM; de Vries EG; Slooff MJ
    Scand J Gastroenterol; 2004 Nov; 39(11):1141-8. PubMed ID: 15545174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Right trisegment portal vein embolization for biliary tract carcinoma: technique and clinical utility.
    Nagino M; Kamiya J; Kanai M; Uesaka K; Sano T; Yamamoto H; Hayakawa N; Nimura Y
    Surgery; 2000 Feb; 127(2):155-60. PubMed ID: 10686980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deficient response of IL-6 impaired liver regeneration after hepatectomy in patients with viral hepatitis.
    Gotohda N; Iwagaki H; Ozaki M; Kinoshita T; Konishi M; Nakagohri T; Takahashi S; Saito S; Yagi T; Tanaka N
    Hepatogastroenterology; 2008; 55(85):1439-44. PubMed ID: 18795707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum alkaline phosphatase after extensive liver resection: a study in patients with biliary tract carcinoma.
    Nagino M; Nimura Y; Kamiya J; Kanai M; Uesaka K; Hayakawa N; Yamamoto H
    Hepatogastroenterology; 1999; 46(26):766-70. PubMed ID: 10370608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between serum hepatocyte growth factor and survival in untreated hepatocellular carcinoma.
    Vejchapipat P; Tangkijvanich P; Theamboonlers A; Chongsrisawat V; Chittmittrapap S; Poovorawan Y
    J Gastroenterol; 2004 Dec; 39(12):1182-8. PubMed ID: 15622483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clarification of risk factors for hepatectomy in patients with hepatocellular carcinoma.
    Ishikawa M; Yogita S; Miyake H; Fukuda Y; Harada M; Wada D; Tashiro S
    Hepatogastroenterology; 2002; 49(48):1625-31. PubMed ID: 12397750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Weight of resected liver is positively correlated with serum hHGF level.
    Miyata K; Taniguchi H; Takeuchi K; Koyama H; Tanaka H; Takahashi T
    Hepatogastroenterology; 1996; 43(12):1589-93. PubMed ID: 8975970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased growth factor expression after hepatic and pancreatic resection.
    Justinger C; Schlüter C; Oliviera-Frick V; Kopp B; Rubie C; Schilling MK
    Oncol Rep; 2008 Dec; 20(6):1527-31. PubMed ID: 19020737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum endothelin-1 and hepatocyte growth factor levels in patients with obstructive jaundice.
    Higaki I; Yamazaki O; Matsuyama M; Horii K; Kawai S; Tsukamoto T; Tanaka H; Kubo S; Hirohashi K; Kinoshita H
    Hepatogastroenterology; 1999; 46(27):1599-602. PubMed ID: 10430302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of hepatocyte growth factor in patients with biliary atresia.
    Hsieh CS; Huang LT; Lee SY; Huang CC; Lee CL; Chuang JH; Chen CL
    J Pediatr Surg; 2008 Jul; 43(7):1333-7. PubMed ID: 18639691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.